MaxCyte (GB:MXCT) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score a data driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
MaxCyte, Inc. has reported a significant change in share ownership, with investment giant BlackRock, Inc. notifying the acquisition of additional voting rights, reaching a total of 8.42% of the voting rights in MaxCyte as of May 16, 2024. This marks an increase from the previous notification, where BlackRock held 8.32% of the voting rights in the company. The financial community is keenly observing these shifts as BlackRock’s movements in the market could signal strategic positions and influence MaxCyte’s stock.
For further insights into GB:MXCT stock, check out TipRanks’ Stock Analysis page.
